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1. Introduction 
Cyclic 3’,5’-adenosine monophosphate (cyclic 
AMP) regulates the expression of genetic informa- 
tion in bacterial cells by activating the transcription 
of certain genes [l-3]. In animal cells, cyclic AMP 
is involved in the control of several metabolic path- 
ways, through the regulation of the activity of many 
enzymes [4]. Presumably, as in the case of bacterial 
cells, some actions of cyclic AMP are mediated by 
changes in the rate of synthesis of RNA. This is in 
line with the fact that cyclic AMP and its analogue, 
dibutyryl cyclic AMP, have been shown to stimulate 
in vivo and in vitro the synthesis of RNA in many 
tissues [5-91. 
In order to investigate how RNA synthesis is 
influenced by cyclic AMP, we have studied the 
action of this nucleotide upon an RNA synthesizing 
cell-free system. In this paper, we will describe the 
features of the stimulation of transcription by 
cyclic AMP, and discuss the possible site of its action. 
2. Materials and methods 
Calf thymus DNA, phosphoenolpyruvate, dithio- 
threitol and spermidine were from Calbiochem.; 
phosphoenolpyruvate kinase was from Sigma Chem- 
ical Co. Cyclic AMP, cyclic GMP, cyclic UMP and 
cyclic IMP were kindly supplied by Boehringer Mann- 
heim, GmbH. 3H-UTP and 3H-ATP were obtained 
from Schwarz BioResearch Inc., and y-32P-ATP and 
North-Holland Publishing Company - Amsterdam 
3H-uridine were from the Radiochemical Centre, 
Amersham, England. 
For studies dealing with the 3H-uridine incorpo- 
ration into RNA, rat liver slices were incubated at 
37” in 2 ml of Eagle’s medium containing 2 &i of 
3H-uridine. The gas phase was 95% O2 -5% COZ 
After 60 min of incubation, the slices were with- 
drawn, chilled on ice, washed with 0.1 M KCl-0.01 
M phosphate buffer (KCl-PO4 buffer) pH 7.4 and 
homogenized in the same buffer. The homogenate 
was centrifuged 5 min at 10,000 g and the super- 
natant decanted. 50 ~1 aliquots of the supernatant 
were then precipitated with cold TCA (0.5 ml), 
containing 0.1 M sodium pyrophosphate. Five min 
later, the precipitate was filtered on Whatmann 
GF/A glass fiber discs and washed 7 times with 3 ml 
of the 5% TCA-Na pyrophosphate mixture. The 
discs were then dried and counted in Triton X-l 00 
scintillation liquid (1 1 of Triton X- 100; 2 I of toluene; 
165 ml of Liquifluor). The results were expressed as 
counts/min/mg of tissue. 
Rat liver RNA polymerase was prepared according 
to the method of Roeder and Rutter [lo] . The 
method of Walton and Garren [ 111 was followed for 
the preparation of the factor necessary for the stimu- 
lation of RNA synthesis by cyclic AMP and for the 
assay of the cyclic AMP binding activity. The fraction 
used corresponded to the component S-l 1 of the 
preparation of Walton and Garren [ 1 l] . 
The RNA polymerase assay was carried out accord- 
ing to Roeder and Rutter [ 121. After the incubation, 
the reaction was stopped by adding 1 ml of ice-cold 
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Table 1 
The effect of dibutyryl cyclic AMP and cyclic AMP on RNA synthesis by rat liver slices and in a cell-free system. 
Rat liver slices 
System 
Calf thymus DNA 
rat liver RNA 
Compound Cone 3H-uridine incorporated 3H-UMP incorporated 
(M) (cpm/mg tissue) (pmoles/0.125 ml) 
None _ 1470 23 
Cyclic AMP 5 x 1o-4 1480 23 
Cyclic AMP 5 x 1o-s 1460 22 
Cyclic AMP 5 x 1o-6 1470 23 
Dibutyryl cyclic AMP 5 x IO4 2500 _ 
Rat liver slices were incubated in 2 ml of Eagle’s medium, containing 2 PCi of 3H-uridine at 37” for 60 min. After this period, 
the slices were washed in ice-cold 0.1 M KCl-0.01 M phosphate buffer (KCI-PO4 buffer) pH 7.4 and homogenized in the same 
buffer. The homogenate was then processed as described in Materials and methods. The assay mixture for RNA polymerase 
activity contained in a volume of 0.125 ml: 10 fig native calf thymus DNA, 2.5 c(g pyruvate kinase, 0.5 pmole phosphoenol- 
pyruvate, 7 Mmole of Tris-HCl buffer (pH 7.9), 0.2 wmole MnCl2, 0.75 pmole NaF, 0.2 @mole dithiothreitol, 0.075 pmole of 
GTP, CTP, ATP, 0.0125 pmole of unlabelled UTP, 1 PCi of 3H-UTP (2 Ci/mmole), 0.046 rmole of ammonium sulfate and 
50 pg of enzyme preparation. After the incubation at 30” for 20 min. the TCA-insoluble material was processed as described 
in Materials and methods. 
TCA containing 0.1 M sodium pyrophosphate. Acid- 
insoluble material was collected on Whatmann glass- 
fiber discs and washed 7 times with 3 ml of the 5% 
TCA-Na pyrophosphate solution. Once completely 
dried, the discs were solubilized and counted in 
Triton X-100 scintillation liquid. 
Protein concentration was determined by the 
biuret method [ 131. 
3. Results and discussion 
Dibutyryl cyclic AMP stimulates the synthesis 
of RNA in rat liver slices, whereas cyclic AMP does 
not (table 1). This discrepancy is probably due to 
the better solubility of the substituted derivative 
which facilitates its penetration into the cells. How- 
ever, cyclic AMP, directly added to an RNA syn- 
thesizing cell-free system containing calf thymus 
DNA and rat liver RNA polymerase, fails to stim- 
ulate transcription. Among the several possible ex- 
planations, the lack of effect could be due to the 
hydrolysis of the cyclic AMP. However, the cyclic 
nucleotide is inactive also in conditions which 
normally prevent its hydrolysis, such as the pres- 
ence of 8 mM theophylline. 
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Since it is well established that mammalian 
tissues contain a cyclic AMP binding protein which 
plays an important role in the action of the cyclic 
nucleotide, we looked for the possibility that a simi- 
lar special factor was needed for the action of cyclic 
AMP on RNA synthesis. We found, indeed, that 
in the presence of a fraction of the cytoplasm of 
rat liver, which precipitates between O-SO% of a 
saturated solution of ammonium sulfate, cyclic 
AMP enhances the synthesis of RNA by calf thymus 
DNA (table 2). The minimal concentration effective 
in stimulating RNA synthesis was 2 X 1 0m6 M. The 
same concentration of the nucleotide, in the absence 
of the stimulating factor, was inactive. Other nucleo- 
tides, such as cyclic GMP, cyclic UMP and cyclic 
IMP do not replace cyclic AMP (data not shown). It 
is noteworthy that the fraction by itself stimulates 
RNA synthesis and has cyclic AMP binding capacity. 
It is also important that, in order to be fully active, 
the stimulating fraction has to be incubated with the 
DNA at least 5 min before the reaction is started by 
the addition of the polymerase. It could be argued 
that the cytoplasmic factor is a type of nuclease 
which nicks the DNA, thus enhancing its template 
activity. However, DNA treated with the fraction 
and reused after phenol extraction, shows the same 
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Table 2 
The effect of cyclic AMP on RNA synthesis in a cell-free system. 
Addition Concentration Stimulating factor 3H-UMP incorporated Stimulation 
(pmoles/O. 125 ml) (%) 
None _ minus 22.8 100 
None _ plus 41.8 210 
Cyclic AMP 2 x lo+ minus 23.0 102 
Cyclic AMP 2 x 1o-6 plus 68.7 302 
The RNA polymerase activity was measured as described in the legend to table 1. Calf thymus DNA was preincubated 5 min at 
30” with 8 fig of the cytoplasmic fraction, with and without cyclic AMP, before the reaction was started by the addition of the 
enzyme. The cytoplasmic activating fraction was dissolved in 10 mM Tris-HCl buffer, pH 7.4, containing 6 mM 2-mercapto- 
ethanol and 8 mM theophylline. 
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Fig. 1. The effect of cyclic AMP on the initiation step of 
RNA synthesis by calf thymus DNA. The RNA polymerase 
activity was measured as described in the legend to table 1, 
except that the concentration of unlabelled UTP and ATP 
were interchanged, and y-32 P-ATP was used in the place of 
3H-UTP. Calf thymus DNA was preincubated with the cyto- 
plasmic fraction at 30” for 5 min, in the presence or absence 
of cyclic AMP, in the conditions indicated in the legend to 
table 2. The amount of the cytoplasmic fraction was 8 wg. 
(0-0-0): Control; (X-X-X): plus cytoplasmic fraction; 
(A-A-~): plus cytoplasmic fraction plus cyclic AMP. 
unstimulated and stimulated levels of transcription 
as DNA which was not previously incubated with 
the cytoplasmic fraction. The characteristics of the 
stimulation of RNA synthesis by this cytoplasmic 
fraction will be described elsewhere (Ambesi-lmpiom- 
bato et al., manuscript in preparation). 
Another feature of the stimulatory effect of cyclic 
AMP is that it seems preferentially to activate the 
initiation step of the transcription. In the presence 
of the stimulating fraction, cyclic AMP enhances 
the incorporation of y-3’ P-ATP into RNA and this 
effect is evident from the onset of the reaction 
(fig. 1). 
So far, most of the actions of cyclic AMP in 
mammalian cells have been related to the stimula- 
tion of protein kinase. One important action of the 
cyclic AMP protein kinases is their ability to phos- 
phorylate histone. Furthermore, it has been recently 
shown that the skeletal muscle protein kinase stim- 
ulates the E. coli RNA polymerase, and cyclic 
AMP enhances this effect [ 141. It has been suggested 
that the stimulatory effect would be mediated by a 
phosphorylation mechanism. In our experiments 
it seems unlikely that phosphorylation of histone 
is involved in the stimulating effect of cyclic AMP 
because no histones were present in the reaction. 
Very likely, cyclic AMP exerts its action directly on 
the DNA template and not on RNA polymerase, 
because the stimulation of RNA synthesis occurs 
only when cyclic AMP and the protein fraction have 
been in contact with the template before the addi- 
tion of the polymerase. 
Acknowledgements 
We thank Dr. Ira Pastan for his helpful suggestions 
and for critical reading of this manuscript. We also 
acknowledge the collaborative participation of the 
medical students Miss Oriana Persico and Miss Beatrice 
Lo Pardo. 
101 
Volume 21, number 1 FEBS LETTERS March 1912 
References 
[ 11 H.E. Varmus, R.L. Perlman and I. Pastan, J. Biol. Chem. 
245 (1970) 2259. 
[2] 2. Miller, H.E. Varmus, J.S. Parks, R.L. Perlman and 
I. Pastan. J. Biol. Chem. 246 (1971) 2419. 
[ 3 1 B. dechrombrugghe, B. Chen, W. Anderson, P. Nissley, 
M. Gottesman, R.L. Perlman and I. Pastan, Nature 
New Biology 231 (1971) 139. 
[4] I. Pastan and R.L. Perlman, Nature New Biology 229 
(1971) 5. 
[S] P.R. Kerkof and J.R. Tata, Biochem. J. 112 (1969) 729. 
16) S.K. Sharma and G.P. Talwar, J. Biol. Chem. 245 (1969) 
1513. 
[7] P.R. Adiga, P.V.N. Murthy and J.M. McKenzie, Bio- 
chemistry 10 (1971) 702. 
]8] M.A. Pisarev, L.J. De Groot and J.F. Wilber, Endo- 
crinology 87 (1970) 339. 
[9] V. Macchia and S. Varrone, FEBS Letters 13 (1971) 
342. 
[lo] R.G. Roeder and W.J. Rutter, Proc. Sot. Natl. Acad. 
Sci. U.S. 65 (1970) 675. 
[I 1] G.M. Walton and L.C. Garren, Biochemistry 9 (1970) 
4223. 
[12] R.G. Roeder and W.J. Rutter, Nature 224 (1969) 234. 
[13] A.G. Gornall, C.J. Bardawill and M.M. David, J. Biol. 
Chem. 177 (1949) 751. 
1141 O.J. Martelo, S.L.C. Woo, E.M. Reimann and E.W. 
Davie, Biochemistry 9 (1970) 4807. 
102 
